Key Takeaways
- Ultradent replaced paper batch records with a Manufacturing Execution System (MES), creating a single source of truth across production, quality, equipment, and operator workflows.
- The MES builds preventive controls into manufacturing by enforcing task sequences, verifying personnel qualifications, and confirming correct materials and instructions.
- Ultradent prioritized implementation based on risk, complexity, and business impact rather than trying to digitize every production line at once.
- The rollout delivered major improvements: variance fell by 40%, correction rates dropped from 21% to 1.8%, quality reviews became faster, and some batch releases decreased from weeks to minutes.
- Expansion from 2 to more than 60 lines was enabled by reusable templates and cross-functional collaboration, showing that successful MES adoption depends as much on people, standards, and continuous improvement as on technology.
In medical device manufacturing, progress isn’t measured in software licenses. It’s measured in trust: the confidence a quality team has in a batch record, the speed an auditor gets to a clean answer, the certainty an operator feels that the step they just completed was the right one.
I spend most of my time working with medical device manufacturers navigating exactly this challenge: how to satisfy FDA 21 CFR Part 820 and ISO 13485 requirements without slowing production to a crawl. This new case study with Ultradent Products Inc. is one of the clearest examples I’ve seen of what happens when a MES stops being a digitization project and becomes the operating model itself.
A Business Too Complex for Paper to Keep Up With
Ultradent began as a family-run business. Today it ships dental materials, devices, instruments, and equipment to more than 130 countries. That growth created a manufacturing footprint spanning nearly 20 product categories: whitening, restorative, hygiene, surgical, orthodontic, endodontic, each with its own specifications, shelf-life requirements, and documentation obligations.
Behind those products sits an equally varied set of processes: formulation, lab chemistry, filling, fabrication, machining, assembly, and packaging. Some lines run in batches, others discretely, and many as a hybrid of both. Standardizing across that mix isn’t optional in a regulated environment, but it’s genuinely hard to do without flattening the differences that make each product safe and compliant.
Ultradent Started With Batch Records and Became Something Bigger
Ultradent’s MES journey began the way most do in this industry: replacing paper batch records with electronic ones. I see this same starting point again and again with the manufacturers I work with, because paper slows reviews, causes manual entry mistakes, and buries teams in corrections.
But the results here confirm something I tell clients early on: digitizing records is only the opening move. Once production data, quality checks, equipment interactions, and operator instructions start flowing through one single source of truth, the technology’s influence spreads well beyond documentation, into scheduling, inventory visibility, and shop-floor decision-making itself.
Building Guardrails Instead of Relying on Hindsight
One of the clearest shifts in Ultradent’s story is the move from catching mistakes to preventing them. Manual review still matters, but it shouldn’t be the last line of defense.
By enforcing the correct sequence of tasks, verifying qualified personnel, and confirming the right materials and instructions at each step, the system builds guardrails directly into the workflow, reducing how much weight sits on a reviewer’s shoulders after the fact.
Prioritizing by Risk, Not by Convenience
Ultradent didn’t try to digitize everything at once. Instead, the team asked a sharper question: where do risk, complexity, and business impact overlap most? That risk-based lens, rather than simply picking the easiest lines to convert, is the piece of advice I give most often to medical device manufacturers starting this journey with limited time and budget.
The Payoff: Fewer Corrections, Faster Releases
The numbers speak plainly. Within two years of going live, while only some whitening lines were connected, Ultradent saw variance drop by 40%. Job corrections told a similarly dramatic story: products outside the system carried a 21% correction rate, compared to just 1.8% for products running through it.
Review and release times shrank too. Quality Review System checks fell from 20 minutes to 9. Batch releases that once took weeks for certain products now typically close out in minutes, occasionally stretching to an hour. That’s not just a speed gain; it reflects cleaner data capture and fewer deviations upstream, which is exactly what auditors want to see.
From 2 Lines to 65
The rollout started small and deliberate, with priority whitening lines first. By 2025, more than 60 production lines were running on the system, every whitening line among them. The trajectory itself tells a story: confidence in a digital system compounds once teams see it work in one place and trust it enough to expand.
Templates were a big part of that scaling. Reusable configurations, covering things like label-reading cameras, label quantities, and HMI integration, let Ultradent avoid treating every new line as a one-off engineering project. That discipline preserved consistency and kept technical debt from piling up as the rollout grew.
Quality metrics improved just as visibly. Common batch-record issues, blank entries, conflicting data, illegible write-overs declined sharply. CP verification nonconformance reports dropped from 20 in 2022 to just 2 in 2025.
Technology Alone Didn’t Get Them There
None of this happened through software alone. Manufacturing, quality, IT, engineering, finance, and shopfloor teams all had a stake in how the system was defined, used, and improved. Ultradent’s leaders were explicit about the need for education and communication, making sure people understood not just how the system worked, but why it mattered for risk, quality, and their own daily tasks.
That cross-functional buy-in is often the difference between a system that’s technically installed and one that’s actually used.
What I Take From This
Ultradent treated its MES rollout as an evolving capability, not a finished project. They started where the risk was clearest, built standards that could scale, measured what mattered, and kept refining the relationship between people and process.
That’s the pattern I now look for in every medical device manufacturer I work with: not whether they’ve bought the software, but whether they’re building that same discipline around it. The result, when they do, is bigger than any single metric. Operators end up with a system they don’t want to give back. Quality teams gain tighter controls. Auditors get clearer evidence, faster. That’s the real promise of MES in regulated manufacturing, not just digital execution, but earned confidence, line by line.
You might also be interested in: Radiating Manufacturing Data for a Healthy Business
